Health & Bio

STAT: Beyond GLP-1—Next-Generation Obesity Drug Research Accelerates (April 16)

STAT reports April 16 that developers are actively exploring non-GLP-1 targets to sidestep adverse effects and resistance. New paradigm emerging.

Primary sources · 1
STAT
← View the full 2026-04-18 (Saturday) issue
What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →